WSJ: Stamford drug company assessed $7M by N.Y.
OxyContin maker Purdue Pharma reportedly owes $7 million to the state of New York, under a new law that assesses opioid sellers $100 million annually over six years.
Stamford-based Purdue Pharma and other companies have sued, the Wall Street Journal reported, arguing New York’s new Opioid Stewardship Act penalizes them unfairly for distributing legal pharmaceuticals.
In addition to opioid makers, the law assesses distributors like McKesson and pharmacies like CVS Health.
Alex.Soule@scni.com; 203-842-2545; @casoulman